Results 111 to 120 of about 15,537 (248)

Comparison of BIOCHIP Mosaic Based Indirect Immunofluorescence and Oral Direct Immunofluorescence in Patients with Oral Mucosal Pemphigus

open access: yesIndian Dermatology Online Journal
Background: Oral mucosal lesions in pemphigus vulgaris may precede cutaneous lesions and can cause diagnostic confusion. Diagnosis can be made by histopathology, direct immunofluorescence (DIF), and indirect immunofluorescence (IIF).
Amrithaa Muralitharan   +2 more
doaj   +1 more source

Aire-Dependent Thymic Expression of Desmoglein 3, the Autoantigen in Pemphigus Vulgaris, and Its Role in T-Cell Tolerance [PDF]

open access: bronze, 2010
Naoko Wada   +8 more
openalex   +1 more source

Persistence of Anti-Desmoglein 3 IgG+ B-Cell Clones in Pemphigus Patients over Years [PDF]

open access: bronze, 2014
Christoph M. Hammers   +6 more
openalex   +1 more source

Role of Desmoglein Autoantibody in the Diagnosis of Pemphigus Vulgaris: A Case Report

open access: yesActa Medica Indonesiana
Pemphigus vulgaris (PV) is a group of autoimmune diseases that cause abnormalities in the form of lesions or blisters on the skin and mucous membranes. It often presents diagnostic challenges due to its varied clinical manifestations. Accurate diagnosis
Diane Lukito Setiawan   +2 more
doaj  

Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: case report and review of the literature

open access: yesDermatology Reports
The discovery of the role of Bruton’s Tyrosine Kinase (BTK) in inflammation and autoimmunity has recently led to the development of BTK inhibitors for the treatment of autoimmune diseases, including pemphigus vulgaris.
Christian Ciolfi   +5 more
doaj  

Rituximab therapy improves recalcitrant Pemphigus vulgaris [PDF]

open access: yes, 2015
Pemphigus is a severe life-threatening blistering disease associated with autoantibodies against cell adhesion proteins desmogleins 1 and 3. Patients with severe pemphigus commonly show high rates of relapse after conventional immunosuppressive therapy ...
Balighi, Kamran   +7 more
core  

Inflammation-induced desmoglein-2 ectodomain shedding compromises the mucosal barrier

open access: green, 2015
Ryuta Kamekura   +7 more
openalex   +1 more source

Figure S6 from Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner

open access: gold, 2023
Alejandra Valenzuela-Iglesias   +6 more
openalex   +1 more source

Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes

open access: green, 2017
Andrew M. Overmiller   +11 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy